Nevertheless, apart from the positive effects of HDAC inhibition on epigenetic brain disorders such as Rett syndrome and Fragile X-linked syndrome, a wealth of evidence shows that alterations of acetylation levels during brain development lead to dramatic negative effects and raising thus the question of whether chemical HDAC inhibitors are safe during developmental stages. The gene discussed is HDAC9; the disease is atypical Rett syndrome.